Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer

World Journal of Surgery

Volumn 33, Issue 1, 2009, Pages 44-51

  Shien, Tadahiko ^a,b   Akashi Tanaka, Sadako ^a   Miyakawa, Kunihisa ^c   Hojo, Takashi ^a   Shimizu, Chikako ^a   Seki, Kunihiko ^a   Ando, Masashi ^a   Kohno, Tsutomu ^a   Taira, Naruto ^b   Doihara, Hiroyoshi ^b   Katsumata, Noriyuki ^a   Fujiwara, Yasuhiro ^a   Kinoshita, Takayuki ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Nagano PET Imaging and Diagnostic Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PACLITAXEL; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TAMOXIFEN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 58149293601     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9800-9     Document Type: Article

References (22)

1. HD Bear S Anderson RE Smith 2006 Sequential preoperatrive or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 24 1 9
2. AU Buzdar NK Ibrahim D Francis DJ Booser ES Thomas RL Theriault L Pusztai MC Green BK Arun SH Giordano M Cristofanilli DK Frye TL Smith KK Hunt SE Singletary AA Sahin MS Ewer TA Buchholz D Berry GN Hortobagyi 2005 Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer J Clin Oncol 23 3676 3685
3. DF Hayes AD Thor LG Dressler D Weaver S Edgerton D Cowan G Broadwater LJ Goldstein S Martino JN Ingle IC Henderson L Norton EP Winer CA Hudis MJ Ellis DA Berry 2007 HER2 and response to paclitaxel in node-positive breast cancer N Engl J Med 357 1496 1506
4. Japanese Breast Cancer Society 2005 General rules for clinical and pathological recording of breast cancer Breast Cancer 12 S12 S14
5. (1981) Histological Typing of Breast Tumours. International Histological Classification of Tumours. No. 2. World Health Organization, Geneva, pp 18-22
6. H Tsuda C Sakamaki S Tsugane T Fukutomi S Hirohashi 1998 Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma Jpn J Clin Oncol 28 5 11
7. B Fisher J Bryant N Wolmark 1998 Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2672 2685
8. N Wolmark J Wang E Mamounas J Bryant B Fisher 2001 Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monographs 30 96 102
9. JY Pierga E Mouret V Laurence V Dieras A Savigioni P Beuzeboc T Dorval T Palangie M Jouve P Pouillart 2003 Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response Eur J Cancer 39 1089 1096
10. MA Bollet B Sigal-Zafrani L Gambotti JM Extra M Meynier C Nos R Dendale F Campana YM Kirova V Dieras A Fourquet for Institute Curie Breast Cancer Study Group 2006 Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study Eur J Cancer 42 2286 2295
11. T Petit M Wilt M Velten R Millon JF Rodier C Borel R Mors P Haegele M Eber JP Ghnassia 2004 Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant Anthracycline-based chemotherapy Eur J Cancer 40 205 211
12. S Amat C Abrial F Penault-Llorca R Delva P Bougnoux B Leduc M-A Mouret-Reynier D Mery-Mignard J-P Bleuse J Dauplat H Cure P Chollet 2005 High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer Breast Cancer Res Treat 94 255 263
13. M Tubiana-Hulin D Stevens S Lasry M Guinebretiere L Bouita C Cohen-Solal P Cherel J Rouesse 2006 Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution Ann Oncol 17 1228 1233
14. VF Cocquyt PN Blondeel HT Depypere MM Praet VR Scelfhout OE Silvia J Hurler RF Serreyn KK Daems SJ Van Belle 2003 Different response to preoperative chemotherapy for invasive lobular carcinoma and invasive ductal carcinoma Eur J Surg Oncol 29 361 367
15. MC Matieu R Rouzier A Llombart-Cussac L Sideris S Koscielny JP Travagli G Contesso S Delaloge M Spielmann 2004 The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile Eur J Cancer 40 342 351
16. JA van der Hage CJ van der Velde JP Julien M Tubiana-Hulin C Vanderveiden L Duchateau Cooperating Investigators 2001 Preoperative chemotherapy in primary operable breast cancer: results from the European oeganization for research and treatment of cancer trial 10902 J Clin Oncol 19 4224 4237
17. A Maklis TJ Powles SE Ashley J Chang T Hickish VA Tidy AG Nash HT Ford 1998 A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer Ann Oncol 9 1179 1184
18. M Moneer M El-Didi H Khaled 1999 Breast conservative surgery: is it appropriate for locally advanced breast cancer following downstaging by neoadjuvant chemotherapy? A pathological assessment Breast 8 315 319
19. S Akashi-Tanaka T Fukutomi N Sato E Iwamoto T Watanabe N Katsumata M Ando K Miyakawa T Hasegawa 2004 The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery Ann Surg 239 238 243
20. F Puglisi M Mansutti G Aprile AM Minisini C Di Loreto M Bazzocchi V Londero C Cedolini G Gentile S Pizzolitto A Piga A Sobrero 2004 Tumor shrinkage evaluation during and after preoperative doxorubicin and cyclophosphamide followed by docetaxel in patients with breast cancer Anticancer Res 24 2487 2494
21. A Goldhirsch WC Wood RD Gelber 2007 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 1133 1144
22. T Shien T Tashiro M Omatsu T Masuda K Furuta N Sato S Akashi-Tanaka M Uehara E Iwamoto T Kinoshita T Fukutomi H Tsuda T Hasegawa 2005 Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation J Clin Pathol 58 1299 1304